GBI and Allterum to Manufacture Therapeutic Antibody for Clinical Trials
With this collaboration, GBI will leverage their extensive expertise in manufacturing complex biologics to ensure the high-quality production of 4A10 for Phase 1/2a clinical trials.
Monoclonal Antibody | 08/10/2024 | By Aishwarya
Sanofi Begins Shipping BEYFORTUS in US
Sanofi has started shipping BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection doses in the US to private healthcare providers and to the Centers for Disease Control and Prevention for its vaccines for children program.
Monoclonal Antibody | 18/09/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy